Evogliptin and Impurities
Evogliptin-d9 L-Tartarate
CAS:1222102-51-3
Formula:
C19H17D9F3N3O3·C4H6O6
Molecular weight:
410.49 150.09
Ref: 4Z-E-099006
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
Ref: 4Z-E-099001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Thursday 5 Dec 2024
Ref: 4Z-E-099003
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Ref: 4Z-E-099004
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Ref: 4Z-E-099005
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Ref: 4Z-E-099002
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Ref: 4Z-E-099007
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Wednesday 11 Dec 2024
Evogliptin
CAS:1222102-29-5
Evogliptin (DA-1229) is an oral DPP4 inhibitor effective in reducing blood sugar and liver inflammation.
Formula:
C19H26F3N3O3
Color and Shape:
Liquid
Molecular weight:
401.42
Ref: TM-T61949
25mg | 1,437.00 € | ||
50mg | 1,872.00 € | ||
100mg | 2,364.00 € |
Estimated delivery in United States, on Wednesday 22 Jan 2025
Evogliptin HCl
CAS:1246960-27-9
Evogliptin (DA-1229), a DPP4 inhibitor, enhances insulin sensitivity and delays diabetes onset.
Formula:
C19H27ClF3N3O3
Color and Shape:
Solid
Molecular weight:
437.88
Ref: TM-T31732
25mg | 1,418.00 € | ||
50mg | 1,846.00 € | ||
100mg | 2,331.00 € |
Estimated delivery in United States, on Wednesday 22 Jan 2025